FMR LLC 13D and 13G filings for Rapport Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 10:34 am Purchase | 2024-11-08 | 13G | Rapport Therapeutics, Inc. Common Stock RAPP | FMR LLC | 5,486,468 14.999% | 503,117 (+10.10%) | Filing |
| 2024-07-10 10:10 am Purchase | 2024-07-09 | 13G | Rapport Therapeutics, Inc. Common Stock RAPP | FMR LLC | 4,983,351 13.624% | 4,983,351 (New Position) | Filing |